298 related articles for article (PubMed ID: 30536402)
1. Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis.
Hosseini A; Masjedi A; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Anvari E; Jadidi-Niaragh F
J Cell Physiol; 2019 Jul; 234(7):9943-9955. PubMed ID: 30536402
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.
Montes Diaz G; Fraussen J; Van Wijmeersch B; Hupperts R; Somers V
Sci Rep; 2018 May; 8(1):8194. PubMed ID: 29844361
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate downregulates the immune response through the HCA
von Glehn F; Dias-Carneiro RPC; Moraes AS; Farias AS; Silva VAPG; Oliveira FTM; Silva CEBG; de Carvalho F; Rahal E; Baecher-Allan C; Santos LMB
Mult Scler Relat Disord; 2018 Jul; 23():46-50. PubMed ID: 29763776
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies.
Montes Diaz G; Hupperts R; Fraussen J; Somers V
Autoimmun Rev; 2018 Dec; 17(12):1240-1250. PubMed ID: 30316988
[TBL] [Abstract][Full Text] [Related]
7. Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Nicholas JA; Boster AL; Imitola J; O'Connell C; Racke MK
Drug Des Devel Ther; 2014; 8():897-908. PubMed ID: 25045248
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Schulze-Topphoff U; Varrin-Doyer M; Pekarek K; Spencer CM; Shetty A; Sagan SA; Cree BA; Sobel RA; Wipke BT; Steinman L; Scannevin RH; Zamvil SS
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4777-82. PubMed ID: 27078105
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature.
Dello Russo C; Scott KA; Pirmohamed M
Pharmacol Ther; 2021 Mar; 219():107710. PubMed ID: 33091427
[TBL] [Abstract][Full Text] [Related]
10. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
Smith MD; Calabresi PA; Bhargava P
Eur J Immunol; 2018 Feb; 48(2):380-383. PubMed ID: 29108094
[TBL] [Abstract][Full Text] [Related]
11. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases.
Majkutewicz I
Eur J Pharmacol; 2022 Jul; 926():175025. PubMed ID: 35569547
[TBL] [Abstract][Full Text] [Related]
12. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells.
Fiedler SE; Kerns AR; Tsang C; Tsang V; Bourdette D; Salinthone S
Biochem Biophys Res Commun; 2016 Jun; 475(1):19-24. PubMed ID: 27157139
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera
Lategan TW; Wang L; Sprague TN; Rousseau FS
CNS Drugs; 2021 May; 35(5):567-574. PubMed ID: 33797063
[TBL] [Abstract][Full Text] [Related]
16. Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Haarmann A; Nehen M; Deiß A; Buttmann M
Int J Mol Sci; 2015 Aug; 16(8):19086-95. PubMed ID: 26287168
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl Fumarate Reduces Oxidative Stress and Pronociceptive Immune Responses in a Murine Model of Complex Regional Pain Syndrome.
Guo TZ; Shi X; Li W; Wei T; Kingery WS; Clark JD
Anesth Analg; 2021 May; 132(5):1475-1485. PubMed ID: 33646995
[TBL] [Abstract][Full Text] [Related]
18. [Dimethyl Fumarate in Multiple Sclerosis].
Tanaka M; Shimizu Y
Brain Nerve; 2017 Sep; 69(9):1041-1046. PubMed ID: 28900067
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl fumarate in a patient with multiple sclerosis and type 1 diabetes mellitus: The importance of ketonuria.
Krzystanek E; Jarosz-Chobot P
Mult Scler Relat Disord; 2018 Apr; 21():42-45. PubMed ID: 29455073
[TBL] [Abstract][Full Text] [Related]
20. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
Brück J; Dringen R; Amasuno A; Pau-Charles I; Ghoreschi K
Exp Dermatol; 2018 Jun; 27(6):611-624. PubMed ID: 29603404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
